N-acetylmannosamine

Generic Name: N-acetylmannosamine

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₈H_₁₅NO_₆

CAS Number: 3615-17-6

Unique Ingredient Identifier: X80PR7P73R

Background: N-acetylmannosamine is under investigation for the other of GNE Myopathy.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis

Phase 2

Not yet recruiting

Conditions: Focal Segmental Glomerulosclerosis

Interventions: Drug: ManNAc

First Posted Date: 2024-10-30

Last Posted Date: 2024-12-20

Lead Sponsor: National Human Genome Research Institute (NHGRI)

Target Recruit Count: 30

Registration Number: NCT06664814

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Multi-Center Study of ManNAc for GNE Myopathy

Phase 2

Active, not recruiting

Conditions: GNE Myopathy

Interventions: Other: Placebo
Drug: ManNAc

First Posted Date: 2020-01-18

Last Posted Date: 2024-10-17

Lead Sponsor: Leadiant Biosciences, Inc.

Target Recruit Count: 54

Registration Number: NCT04231266

Locations: 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
University of Kansas, Medical Center, Kansas City, Kansas, United States

and more 7 locations

An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy

Phase 2

Completed

Conditions: GNE Myopathy

Interventions: Drug: ManNAc

First Posted Date: 2015-01-27

Last Posted Date: 2019-04-16

Lead Sponsor: National Human Genome Research Institute (NHGRI)

Target Recruit Count: 12

Registration Number: NCT02346461

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

Phase 1

Completed

Conditions: GNE Myopathy
Hereditary Inclusion Body Myopathy (HIBM)

Interventions: Drug: ManNAc

First Posted Date: 2012-07-06

Last Posted Date: 2017-10-19

Lead Sponsor: National Human Genome Research Institute (NHGRI)

Target Recruit Count: 26

Registration Number: NCT01634750

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy